Image via LiveMint
Last updated
Dr Reddy's Laboratories: Product Launch
Dr Reddy's launching generic semaglutide in Canada (first regulatory approval) and expanding oral semaglutide in India with plans to enter 80+ countries over two years
Source: LiveMint
The leadership read
Product momentum tends to widen the sector product and commercial leadership bench strength.
Market context: MitchelLake's Talent Market Index sits at 105.9 (Hot), down 2.3 on the prior month; Asia hiring signal is running steady (+0.5pts).
Dr Reddy's Laboratories: 2 signals in the last 90 days; 0.1% of MitchelLake's Asia signal flow; 2 tracked across 32 days.
MitchelLake in this thematic
Also at Dr Reddy's Laboratories →
More signals across Asia
Product Launch · Asia
Leonardo →Leonardo announced a deal with Indonesian Air Force to supply 12 M-346F Block 20 light fighters, making Indonesia the 23rd operator and first Asian customer of the Block 20 variant. First deliveries expected 2030. Deal includes localization of support, maintenance, overhaul and training capabilities.
Product Launch · Asia
GEODIS →GEODIS launches electric vehicle delivery solution in Vietnam using VinFast EC Van 2026 for last-mile B2B and B2C logistics in luxury and retail sectors. One of first logistics providers to introduce electric urban distribution in Vietnam.
Product Launch · Asia
BYD →BYD launched the Denza Z9GT, a luxury four-door EV shooting brake with 1,100 horsepower at RM359,000, featuring proprietary flash-charging technology that charges 10-70% in five minutes
Product Launch · Asia
Dell Technologies →Dell Technologies India positioning liquid cooling solutions as fastest-growing adoption area for AI infrastructure across neoclouds and sovereign AI projects
Product Launch · Asia
Takeda →Takeda's dengue vaccine (TAK-003) received India's Drug Controller General of India (DCGI) marketing authorization approval, becoming India's first-ever approved dengue vaccine. The vaccine is approved for ages 4-60 without pre-vaccination testing, regardless of previous dengue exposure.
Product Launch · Asia
Paytm →Paytm is investing 1 billion rupees (US$10.4 million) into Paytm Money, its wholly owned stockbroking subsidiary, signaling expansion into wealth and investment services.
Intelligence powered by Autonodal ↗